Trim21 promotes inflammation in keratinocytes of psoriatic patients

Area of Science:

• Dermatology
• Immunology
• Molecular Biology

Background:

• Psoriasis is a prevalent inflammatory skin condition with significant physical and psychological impacts.
• Current understanding of psoriasis pathogenesis requires further elucidation of key molecular players.
• E3 ligases, such as Trim21, are increasingly recognized for their roles in inflammatory diseases.

Purpose of the Study:

• To investigate the role of E3 ligase Trim21 in regulating keratinocyte inflammation in psoriasis.
• To determine if targeting Trim21 could serve as a potential therapeutic strategy for psoriasis.

Main Methods:

• Utilized a knockdown technique to reduce Trim21 expression in keratinocytes.
• Assessed inflammatory markers and chemical mediators in response to Trim21 modulation.
• Screened for interacting molecules, specifically identifying p65's direct interaction with Trim21.
• Evaluated the effect of Trim21 knockdown on psoriasis-like skin lesions in vivo.

Main Results:

• Knockdown of Trim21 significantly reduced inflammation in keratinocytes.
• Trim21 was found to directly interact with the inflammatory molecule p65.
• Reduced Trim21 expression markedly decreased the severity of skin lesions characteristic of psoriasis.

Conclusions:

• Increased Trim21 expression in psoriatic skin contributes to inflammation.
• Trim21 represents a promising molecular target for novel psoriasis therapies.
• Targeting Trim21 offers a potential strategy to mitigate psoriasis-associated inflammation and skin lesions.